Recent policy changes at the CDC have raised concerns following a cyclospora outbreak in the United States. The parasite, previously listed as a mandatory disease to monitor, was removed from the agency's surveillance requirements. Public health experts are now examining whether this administrative decision may have contributed to delayed detection and response capabilities, highlighting the potential risks of reducing epidemiological oversight during disease control efforts.

Summary auto-generated by AI from the original publisher's content. Editorial standards.